Free Trial
NASDAQ:LSB

Lakeshore Biopharma (LSB) Stock Price, News & Analysis

Lakeshore Biopharma logo
$1.07 -0.07 (-6.05%)
Closing price 05/23/2025 03:58 PM Eastern
Extended Trading
$1.07 0.00 (-0.09%)
As of 05/23/2025 06:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Lakeshore Biopharma Stock (NASDAQ:LSB)

Key Stats

Today's Range
$1.09
$1.10
50-Day Range
$1.07
$2.78
52-Week Range
$1.01
$11.20
Volume
1,916 shs
Average Volume
20,369 shs
Market Capitalization
$9.97 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

LakeShore Biopharma Co., Ltd. engages in the provision of discovering, developing, manufacturing, and commercializing vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on developing PIKA technology platform. It operates through the People's Republic of China and Other Countries or Regions. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in Beijing, China.

Receive LSB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lakeshore Biopharma and its competitors with MarketBeat's FREE daily newsletter.

LSB Stock News Headlines

Memorial Day Sale! 82% Off Disruptors and Dominators!
Jensen Huang recently gave the keynote speech at the Consumer Electronics Show in Las Vegas. When the Nvidia CEO walked on stage, you could've heard a pin drop. Why? Robots — built by Nvidia.
LakeShore Biopharma’s Financial Leap and Rabies Vaccine Trial Approval
See More Headlines

LSB Stock Analysis - Frequently Asked Questions

Lakeshore Biopharma's stock was trading at $3.46 at the start of the year. Since then, LSB shares have decreased by 69.0% and is now trading at $1.0710.
View the best growth stocks for 2025 here
.

Lakeshore Biopharma's stock reverse split on Friday, October 4th 2024. The 1-10 reverse split was announced on Friday, September 27th 2024. The number of shares owned by shareholders was adjusted after the market closes on Thursday, October 3rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of LSB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Lakeshore Biopharma investors own include Jiuzi (JZXN), Aethlon Medical (AEMD), Aditxt (ADTX), Adial Pharmaceuticals (ADIL), Avalon GloboCare (ALBT), Ainos (AIMD) and AMC Entertainment (AMC).

Company Calendar

Today
5/24/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:LSB
Previous Symbol
NASDAQ:LSB
Web
N/A
Fax
N/A
Employees
773
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$672.27 million
Price / Cash Flow
N/A
Book Value
$8.86 per share
Price / Book
0.12

Miscellaneous

Free Float
N/A
Market Cap
$9.97 million
Optionable
N/A
Beta
0.64
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (NASDAQ:LSB) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners